NKAP_HUMAN - dbPTM
NKAP_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NKAP_HUMAN
UniProt AC Q8N5F7
Protein Name NF-kappa-B-activating protein
Gene Name NKAP
Organism Homo sapiens (Human).
Sequence Length 415
Subcellular Localization Nucleus .
Protein Description Acts as a transcriptional repressor. Plays a role as a transcriptional corepressor of the Notch-mediated signaling required for T-cell development. Also involved in the TNF and IL-1 induced NF-kappa-B activation. Associates with chromatin at the Notch-regulated SKP2 promoter..
Protein Sequence MAPVSGSRSPDREASGSGGRRRSSSKSPKPSKSARSPRGRRSRSHSCSRSGDRNGLTHQLGGLSQGSRNQSYRSRSRSRSRERPSAPRGIPFASASSSVYYGSYSRPYGSDKPWPSLLDKEREESLRQKRLSERERIGELGAPEVWGLSPKNPEPDSDEHTPVEDEEPKKSTTSASTSEEEKKKKSSRSKERSKKRRKKKSSKRKHKKYSEDSDSDSDSETDSSDEDNKRRAKKAKKKEKKKKHRSKKYKKKRSKKSRKESSDSSSKESQEEFLENPWKDRTKAEEPSDLIGPEAPKTLTSQDDKPLNYGHALLPGEGAAMAEYVKAGKRIPRRGEIGLTSEEIASFECSGYVMSGSRHRRMEAVRLRKENQIYSADEKRALASFNQEERRKRENKILASFREMVYRKTKGKDDK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Phosphorylation---MAPVSGSRSPDR
---CCCCCCCCCCCC
29.9623401153
7Phosphorylation-MAPVSGSRSPDREA
-CCCCCCCCCCCCCC
23.2923401153
9PhosphorylationAPVSGSRSPDREASG
CCCCCCCCCCCCCCC
32.6123401153
15PhosphorylationRSPDREASGSGGRRR
CCCCCCCCCCCCCCC
28.8323927012
17PhosphorylationPDREASGSGGRRRSS
CCCCCCCCCCCCCCC
35.2623927012
23PhosphorylationGSGGRRRSSSKSPKP
CCCCCCCCCCCCCCC
36.8328985074
24PhosphorylationSGGRRRSSSKSPKPS
CCCCCCCCCCCCCCC
39.7228985074
25PhosphorylationGGRRRSSSKSPKPSK
CCCCCCCCCCCCCCC
38.1028985074
27PhosphorylationRRRSSSKSPKPSKSA
CCCCCCCCCCCCCCC
39.8533259812
31PhosphorylationSSKSPKPSKSARSPR
CCCCCCCCCCCCCCC
45.4230177828
33PhosphorylationKSPKPSKSARSPRGR
CCCCCCCCCCCCCCC
33.0020860994
46PhosphorylationGRRSRSHSCSRSGDR
CCCCCCCCCCCCCCC
18.29-
50PhosphorylationRSHSCSRSGDRNGLT
CCCCCCCCCCCCCCC
28.8428450419
57PhosphorylationSGDRNGLTHQLGGLS
CCCCCCCCCCCCCCC
14.6928450419
64PhosphorylationTHQLGGLSQGSRNQS
CCCCCCCCCCCCCHH
35.4517525332
67PhosphorylationLGGLSQGSRNQSYRS
CCCCCCCCCCHHHHH
22.0328450419
78PhosphorylationSYRSRSRSRSRERPS
HHHHHHCCCCCCCCC
35.5420068231
80PhosphorylationRSRSRSRSRERPSAP
HHHHCCCCCCCCCCC
39.4820363803
85PhosphorylationSRSRERPSAPRGIPF
CCCCCCCCCCCCCCC
58.0623312004
94PhosphorylationPRGIPFASASSSVYY
CCCCCCCCCCCCEEE
29.1224144214
96PhosphorylationGIPFASASSSVYYGS
CCCCCCCCCCEEEEC
22.2024144214
97PhosphorylationIPFASASSSVYYGSY
CCCCCCCCCEEEECC
24.4424144214
98PhosphorylationPFASASSSVYYGSYS
CCCCCCCCEEEECCC
16.1924144214
100PhosphorylationASASSSVYYGSYSRP
CCCCCCEEEECCCCC
12.2124144214
101PhosphorylationSASSSVYYGSYSRPY
CCCCCEEEECCCCCC
9.4624144214
103PhosphorylationSSSVYYGSYSRPYGS
CCCEEEECCCCCCCC
12.1024144214
104PhosphorylationSSVYYGSYSRPYGSD
CCEEEECCCCCCCCC
12.3424144214
105PhosphorylationSVYYGSYSRPYGSDK
CEEEECCCCCCCCCC
28.6024144214
108PhosphorylationYGSYSRPYGSDKPWP
EECCCCCCCCCCCCH
28.3124144214
110PhosphorylationSYSRPYGSDKPWPSL
CCCCCCCCCCCCHHH
36.3024144214
112AcetylationSRPYGSDKPWPSLLD
CCCCCCCCCCHHHCC
51.1619608861
149PhosphorylationAPEVWGLSPKNPEPD
CCCCCCCCCCCCCCC
29.8619664994
151UbiquitinationEVWGLSPKNPEPDSD
CCCCCCCCCCCCCCC
80.09-
157PhosphorylationPKNPEPDSDEHTPVE
CCCCCCCCCCCCCCC
56.4629255136
161PhosphorylationEPDSDEHTPVEDEEP
CCCCCCCCCCCCCCC
27.2929255136
171PhosphorylationEDEEPKKSTTSASTS
CCCCCCCCCCCCCCC
42.9428102081
172PhosphorylationDEEPKKSTTSASTSE
CCCCCCCCCCCCCCH
33.3828102081
173PhosphorylationEEPKKSTTSASTSEE
CCCCCCCCCCCCCHH
29.4128102081
174PhosphorylationEPKKSTTSASTSEEE
CCCCCCCCCCCCHHH
21.9528102081
176PhosphorylationKKSTTSASTSEEEKK
CCCCCCCCCCHHHHH
32.0328985074
177PhosphorylationKSTTSASTSEEEKKK
CCCCCCCCCHHHHHH
39.6130576142
178PhosphorylationSTTSASTSEEEKKKK
CCCCCCCCHHHHHHH
40.2830576142
209PhosphorylationSKRKHKKYSEDSDSD
HHHHHHHCCCCCCCC
23.3030576142
210PhosphorylationKRKHKKYSEDSDSDS
HHHHHHCCCCCCCCC
43.7530576142
213PhosphorylationHKKYSEDSDSDSDSE
HHHCCCCCCCCCCCC
34.6630576142
215PhosphorylationKYSEDSDSDSDSETD
HCCCCCCCCCCCCCC
42.8630576142
224PhosphorylationSDSETDSSDEDNKRR
CCCCCCCCHHHHHHH
48.07-
249PhosphorylationKKHRSKKYKKKRSKK
HHHHHHHHHHHHHHH
31.60-
261PhosphorylationSKKSRKESSDSSSKE
HHHHHHHCCCCCCHH
42.3417081983
262PhosphorylationKKSRKESSDSSSKES
HHHHHHCCCCCCHHH
42.4717081983
264PhosphorylationSRKESSDSSSKESQE
HHHHCCCCCCHHHHH
38.1617081983
265PhosphorylationRKESSDSSSKESQEE
HHHCCCCCCHHHHHH
50.8817081983
266PhosphorylationKESSDSSSKESQEEF
HHCCCCCCHHHHHHH
44.3817081983
269PhosphorylationSDSSSKESQEEFLEN
CCCCCHHHHHHHHHC
46.7817081983
280UbiquitinationFLENPWKDRTKAEEP
HHHCCCCCCCCCCCC
60.6624816145
282PhosphorylationENPWKDRTKAEEPSD
HCCCCCCCCCCCCHH
44.7528555341
283SumoylationNPWKDRTKAEEPSDL
CCCCCCCCCCCCHHC
55.48-
283UbiquitinationNPWKDRTKAEEPSDL
CCCCCCCCCCCCHHC
55.48-
283SumoylationNPWKDRTKAEEPSDL
CCCCCCCCCCCCHHC
55.4828112733
298PhosphorylationIGPEAPKTLTSQDDK
CCCCCCCCCCCCCCC
33.9229978859
300PhosphorylationPEAPKTLTSQDDKPL
CCCCCCCCCCCCCCC
29.5829978859
301PhosphorylationEAPKTLTSQDDKPLN
CCCCCCCCCCCCCCC
34.4228464451
305UbiquitinationTLTSQDDKPLNYGHA
CCCCCCCCCCCCCCC
60.7429967540
305AcetylationTLTSQDDKPLNYGHA
CCCCCCCCCCCCCCC
60.7426051181
305SumoylationTLTSQDDKPLNYGHA
CCCCCCCCCCCCCCC
60.7428112733
309PhosphorylationQDDKPLNYGHALLPG
CCCCCCCCCCCCCCC
20.2629978859
324PhosphorylationEGAAMAEYVKAGKRI
CHHHHHHHHHCCCCC
9.5627642862
326UbiquitinationAAMAEYVKAGKRIPR
HHHHHHHHCCCCCCC
50.9829967540
334MethylationAGKRIPRRGEIGLTS
CCCCCCCCCCCCCCH
41.56115485057
352PhosphorylationASFECSGYVMSGSRH
HEEECCEEECCCCHH
4.08-
355PhosphorylationECSGYVMSGSRHRRM
ECCEEECCCCHHHHH
24.47-
357PhosphorylationSGYVMSGSRHRRMEA
CEEECCCCHHHHHHH
20.01-
374PhosphorylationLRKENQIYSADEKRA
HHHHCCCCCHHHHHH
6.5030576142
375PhosphorylationRKENQIYSADEKRAL
HHHCCCCCHHHHHHH
30.7621815630
379UbiquitinationQIYSADEKRALASFN
CCCCHHHHHHHHHCC
43.4424816145
400PhosphorylationRENKILASFREMVYR
HHHHHHHHHHHHHHH
22.7624719451

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of NKAP_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NKAP_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NKAP_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
F124A_HUMANFAM124Aphysical
16189514
CEP70_HUMANCEP70physical
16189514
LC7L2_HUMANLUC7L2physical
16169070
PR40A_HUMANPRPF40Aphysical
22365833
DHX15_HUMANDHX15physical
22365833
U2AF1_HUMANU2AF1physical
22365833
BUB3_HUMANBUB3physical
22365833
RBM39_HUMANRBM39physical
22365833
PRPF3_HUMANPRPF3physical
22365833
RBMX2_HUMANRBMX2physical
22365833
DDX41_HUMANDDX41physical
22365833
DHX8_HUMANDHX8physical
22365833
PPIG_HUMANPPIGphysical
22365833
F10C1_HUMANFRA10AC1physical
22365833
PCBP2_HUMANPCBP2physical
22365833
NKAP_HUMANNKAPphysical
22365833
TTC14_HUMANTTC14physical
22365833
NKAPL_HUMANNKAPLphysical
28514442
CAPON_HUMANNOS1APphysical
28514442
DDX41_HUMANDDX41physical
28514442
CA226_HUMANC1orf226physical
28514442
CSK21_HUMANCSNK2A1physical
28514442
JMJD6_HUMANJMJD6physical
28514442
NINL_HUMANNINLphysical
28514442
CHD9_HUMANCHD9physical
28514442
CSK2B_HUMANCSNK2Bphysical
28514442
FRIL_HUMANFTLphysical
28514442
TOPRS_HUMANTOPORSphysical
28514442
UBP7_HUMANUSP7physical
28514442
RNPS1_HUMANRNPS1physical
28514442
ZZEF1_HUMANZZEF1physical
28514442
RBM25_HUMANRBM25physical
28514442
PININ_HUMANPNNphysical
28514442
ARMC8_HUMANARMC8physical
28514442
ZCH18_HUMANZC3H18physical
28514442
SRRM2_HUMANSRRM2physical
28514442
HECD3_HUMANHECTD3physical
28514442
CBY1_HUMANCBY1physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NKAP_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-112, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149; SER-157 ANDTHR-161, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9; SER-149; SER-261;SER-262; SER-264; SER-265; SER-266 AND SER-269, AND MASS SPECTROMETRY.
"Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC.";
Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.;
Proteomics 5:3589-3599(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149, AND MASSSPECTROMETRY.

TOP